Malignant mesothelioma of the peritoneum: Case reports and immunohistochemical findings including Ki-67 expression

Medical Molecular Morphology

Volumn 43, Issue 1, 2010, Pages 53-59

  Hirano, Hiroshi ^a   Fujisawa, Takashi ^a   Maekawa, Koichi ^a   Ohkubo, Eriko ^b   Okimura, Akira ^a   Kuribayashi, Kozo ^c   Nakano, Takashi ^c   Nakasho, Keiji ^c   Nishigami, Takashi ^c  

^a Nippon Steel Hirohata Hospital   (Japan)

^b Takasago Municipal Hospital   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Histological features; Immunohistochemistry; Ki 67 labeling index; Long survival period; Malignant mesothelioma of the peritoneum

Indexed keywords

KI 67 ANTIGEN;

ABDOMINAL DISTENSION; AGED; ANTIGEN EXPRESSION; ARTICLE; AUTOPSY; CANCER SURVIVAL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DYSPNEA; EDEMA; FATIGUE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PERITONEUM MESOTHELIOMA; PRIORITY JOURNAL;

AGED; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MESOTHELIOMA; NEOPLASM METASTASIS; PERITONEAL NEOPLASMS; SURVIVORS;

EID: 77954580532     PISSN: 18601480     EISSN: 18601499     Source Type: Journal    
DOI: 10.1007/s00795-009-0460-0     Document Type: Article

References (30)

1. Hillerdal G (1983) Malignant mesothelioma 1982: review of 4710 published cases. Br J Dis Chest 77:321-343
2. Suzuki Y (2001) Pathology of human malignant mesothelioma: preliminary analysis of 1,517 mesothelioma cases. Ind Health 39:183-185
3. Spirtas R, Connelly RR, Tucker MA (1988) Survival patterns for malignant mesothelioma: the SEER experience. Int J Cancer 41:525-1330
4. Kerrigan SA, Turnnir RT, Clement PB, Young RH, Churg A (2002) Diffuse malignant epithelial mesotheliomas of the peritoneum in women: a clinicopathologic study of 25 patients. Cancer (Phila) 94:378-385
5. Geary WA, Mills SE, Frierson HF Jr, Pope TL (1991) Malignant peritoneal mesothelioma in childhood with long-term survival. Am J Clin Pathol 95:493-498
6. Chu AY, Litzky LA, Pasha TL, Acs G, Zhang PJ (2005) Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Mod Pathol 18:105-110
7. Comin CE, Saieva C, Messerini L (2007) H-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary. Am J Surg Pathol 31:1139-1148
8. Battifora H, McCaughey WTE (1994) Tumors of the serosal membranes. Fascicle 15. Atlas of tumor pathology, 3rd series. Armed Forces Institute of Pathology, Washington DC, pp 49-51
9. Daya D, McCaughey WT (1990) Well-differentiated papillary mesothelioma of the peritoneum: a clinicopathologic study of 22 cases. Cancer (Phila) 65:292-296
10. Burrig KF, Pfitzer P, Hort W (1990) Well-differentiated papillary mesothelioma of the peritoneum: a borderline mesothelioma. Report of two cases and review of literature. Virchows Arch A Pathol Anat Histopathol 417:443-447
11. Butnor KJ, Sporn TA, Hammar SP, Roggli VL (2001) Welldifferentiated papillary mesothelioma. Am J Surg Pathol 25: 1304-1309
12. Galateau-Salle F, Vignaud JM, Burke L, Gibbs A, Brambilla E, Attanoos R, Goldberg M, Launoy G, Mesopath group (2004) Well-differentiated papillary mesothelioma of the pleura: a series of 24 cases. Am J Surg Pathol 28:534-540
13. Chahinian AP, Pajak TF, Holland JF, Norton L, Ambinder RM, Mandel EM (1982) Diffuse malignant mesothelioma: prospective evaluation of 69 patients. Ann Intern Med 96:746-755
14. Asensio JA, Goldblatt P, Thomford NR (1990) Primary malignant peritoneal mesothelioma: a report of seven cases and a review of the literature. Arch Surg 125:1477-1481
15. Rogoff EE, Hilaris BS, Huvos AG (1973) Long-term survival in patients with malignant peritoneal mesothelioma treated with irradiation. Cancer (Phila) 32:656-664
16. Sebbag G, Yan H, Shmookler BM, Chang D, Sugarbaker PH (2000) Results of treatment of 33 patients with peritoneal mesothelioma. Br J Surg 87:1587-1593
17. Hirano H, Maeda H, Sawabata N, Okumura Y, Takeda S, Maekura R, Ito M, Maeda T, Nakane S, Uematsu K (2003) Desmoplastic malignant mesothelioma: two cases and a literature review. Med Electron Microsc 36:173-178
18. Comin CE, Anichini C, Boddi V, Novelli L, Dini S (2000) MIB-1 proliferation index correlates with survival in pleural malignant mesothelioma. Histopathology (Oxf) 36:26-31
19. Elmes PC, Simpson JC (1976) The clinical aspects of mesothelioma. Q J Med 45:427-449
20. Brenner J, Sordillo PP, Magill GB, Golbey RB (1982) Malignant mesothelioma of the pleura: review of 123 patients. Cancer (Phila) 49:2431-2435
21. Ito S, Isowa N, Li M, Hasegawa S, Wada H (2005) Parasternal lymph node metastasis of malignant peritoneal mesothelioma: report of a case. Surg Today 35:782-784
22. Weidner N (1991) Malignant mesothelioma of peritoneum. Ultrastruct Pathol 15:515-520
23. Asensio JA, Goldblatt P, Thomford NR (1990) Primary malignant peritoneal mesothelioma. A report of seven cases and a review of the literature. Arch Surg 125:1477-1481
24. Baker PM, Clement PB, Young RH (2005) Malignant peritoneal mesothelioma in women: a study of 75 cases with emphasis on their morphologic spectrum and differential diagnosis. Am J Clin Pathol 123:724-737
25. Jensen V, Sorensen FB, Bentzen SM, Ladekarl M, Nielsen OS, Keller J, Jensen OM (1998) Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas. Histopathology (Oxf) 32(6):536-546
26. Garzetti GG, Ciavattini A, Goteri G, De Nictolis M, Stramazzotti D, Lucarini G, Biagini G (1995) Ki67 antigen immunostaining (MIB 1 monoclonal antibody) in serous ovarian tumors: index of proliferative activity with prognostic significance. Gynecol Oncol 56(2):169-174
27. Gerdes J, Schwab U, Lemke H, Stein H (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31(1):13-20
28. Okimura A, Hirano H, Nishigami T, Ueyama S, Tachibana S, Fukuda Y, Yamanegi K, Ohyama H, Terada N, Nakasho K (2009) Immunohistochemical analyses of E-cadherin, â catenin, CD44s, and CD44v6 expressions, and Ki-67 labeling index in intraductal papillary mucinous neoplasms of the pancreas and associated invasive carcinomas. Med Mol Morphol 42:222-229
29. Hirano H, Tsuji M, Kizaki T, Sashikata T, Yoshi Y, Okada K, Mori H (2002) Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinase, collagens, and Ki67 antigen in pleural malignant mesothelioma: an immunohistochemical and electron microscopic study. Med Electron Microsc 35:16-23
30. Beer TW, Buchanan R, Matthews AW, Stradling R, Pullinger N, Pethybridge RJ (1998) Prognosis in malignant mesothelioma related to MIB 1 proliferation index and histological subtype. Hum Pathol 29:246-251